138 related articles for article (PubMed ID: 14662772)
1. Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis.
De Rosa MF; Sillence D; Ackerley C; Lingwood C
J Biol Chem; 2004 Feb; 279(9):7867-76. PubMed ID: 14662772
[TBL] [Abstract][Full Text] [Related]
2. Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model.
Mattocks M; Bagovich M; De Rosa M; Bond S; Binnington B; Rasaiah VI; Medin J; Lingwood C
FEBS J; 2006 May; 273(9):2064-75. PubMed ID: 16724420
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
4. Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis.
Lala P; Ito S; Lingwood CA
J Biol Chem; 2000 Mar; 275(9):6246-51. PubMed ID: 10692420
[TBL] [Abstract][Full Text] [Related]
5. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of glucosylceramide flip-flop across endoplasmic reticulum: implications for mechanism of glycosphingolipid biosynthesis.
Chalat M; Menon I; Turan Z; Menon AK
J Biol Chem; 2012 May; 287(19):15523-32. PubMed ID: 22427661
[TBL] [Abstract][Full Text] [Related]
7. Cell density-dependent changes of glycosphingolipid biosynthesis in cultured human skin fibroblasts.
Vukelić Z; Kalanj-Bognar S
Glycoconj J; 2001 Jun; 18(6):429-37. PubMed ID: 12084978
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of neutral glycosphingolipid synthesis upon long term inhibition of ceramide synthesis by fumonisin B1.
Meivar-Levy I; Futerman AH
J Biol Chem; 1999 Feb; 274(8):4607-12. PubMed ID: 9988695
[TBL] [Abstract][Full Text] [Related]
9. ATP-binding cassette transporters mediate differential biosynthesis of glycosphingolipid species.
Budani M; Auray-Blais C; Lingwood C
J Lipid Res; 2021; 62():100128. PubMed ID: 34597626
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-induced alterations of the acidic and neutral glycosphingolipids of rat kidney.
Dahiya R; Dudeja PK; Brasitus TA
Biochim Biophys Acta; 1988 Oct; 962(3):390-5. PubMed ID: 3167091
[TBL] [Abstract][Full Text] [Related]
11. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells.
Molinari A; Calcabrini A; Meschini S; Stringaro A; Del Bufalo D; Cianfriglia M; Arancia G
Int J Cancer; 1998 Mar; 75(6):885-93. PubMed ID: 9506534
[TBL] [Abstract][Full Text] [Related]
12. Lactosylceramide is synthesized in the lumen of the Golgi apparatus.
Lannert H; Bünning C; Jeckel D; Wieland FT
FEBS Lett; 1994 Mar; 342(1):91-6. PubMed ID: 8143857
[TBL] [Abstract][Full Text] [Related]
13. Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi.
Lannert H; Gorgas K; Meissner I; Wieland FT; Jeckel D
J Biol Chem; 1998 Jan; 273(5):2939-46. PubMed ID: 9446606
[TBL] [Abstract][Full Text] [Related]
14. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
Goulding CW; Giuliano AE; Cabot MC
Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
[TBL] [Abstract][Full Text] [Related]
15. Construction of a model cell line for the assay of MDR1 (multi drug resistance gene-1) substrates/inhibitors using HeLa cells.
Kugawa F; Suzuki T; Miyata M; Tomono K; Tamanoi F
Pharmazie; 2009 May; 64(5):296-300. PubMed ID: 19530439
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines.
Takara K; Sakaeda T; Yagami T; Kobayashi H; Ohmoto N; Horinouchi M; Nishiguchi K; Okumura K
Biol Pharm Bull; 2002 Jun; 25(6):771-8. PubMed ID: 12081145
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor.
Raggers RJ; Vogels I; van Meer G
Biochem J; 2001 Aug; 357(Pt 3):859-65. PubMed ID: 11463358
[TBL] [Abstract][Full Text] [Related]
19. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells.
Falguières T; Römer W; Amessou M; Afonso C; Wolf C; Tabet JC; Lamaze C; Johannes L
FEBS J; 2006 Nov; 273(22):5205-18. PubMed ID: 17059464
[TBL] [Abstract][Full Text] [Related]
20. Glycolipid transfer protein expression is affected by glycosphingolipid synthesis.
Kjellberg MA; Mattjus P
PLoS One; 2013; 8(7):e70283. PubMed ID: 23894633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
